Alcon AG
NYSE:ALC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Alcon AG
NYSE:ALC
|
CH |
Intrinsic Value
The intrinsic value of 
Alcon AG (ALC) under the Base Case is 93.12 USD per share.
Compared with the current market price of 69.42 USD, the stock appears
Undervalued by 25% .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Alcon Does
Alcon AG is a global eye-care company that makes products used to treat, correct, and care for vision. Its main business is split between surgical eye care and vision care. In surgery, it sells equipment, disposable tools, and implants that eye surgeons use in procedures such as cataract and retinal surgery. In vision care, it sells contact lenses, lens-care products, and other items for everyday eye health.
- Headquarters
- Switzerland CH
- Employees
- 25 000
- IPO date
- Apr 9, 2019
Alcon has a narrow economic moat
Replacing Alcon’s surgical equipment means buying new machines and teaching surgical teams to use them, making a cheaper rival less attractive. Patents on contact lens materials and implanted lens designs also make it harder for competitors to copy important product features.
Read the full moat analysis
Earnings Waterfall
Alcon AG
The intrinsic value for Alcon AG (ALC) under the Base Case is 93.12 USD.
Compared with the current market price of 69.42 USD, the stock appears Undervalued by 25% .